LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers ...
Applying the right formulation strategies early in the drug development process can help avoid costly late-stage failures. Improving R&D productivity continues to be a key challenge for the ...
To optimize the final formulation for a drug, it must meet many criteria beyond producing a safe and effective product. For example, it must be stable and amenable to various manufacturing steps, such ...
AI/ML technologies are revolutionizing pharmaceutical formulation by optimizing excipient selection and predicting stability, reducing time and resources needed for development. Poor solubility of ...
NOTTINGHAM, UK – 4th DECEMBER 2025: Quotient Sciences, a leading global drug development, research and manufacturing accelerator, and Intrepid Labs, the AI leader in pharmaceutical formulation science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results